Article
(18)F-fluorodeoxyglucose positron emission tomography versus computed tomography in predicting histopathological response to epidermal growth factor receptor-tyrosine kinase inhibitor treatment in resectable non-small cell lung cancer.
Annals of surgical oncology - 1 Sept 2014
van Gool Matthijs H, Aukema Tjeerd S, Schaake Eva E, Rijna Herman, Codrington Henk E, Valdés Olmos Renato A, Teertstra Hendrik J, van Pel Renee, Burgers Sjaak A, van Tinteren Harm, Klomp Houke M
Abstract excerpt
PURPOSE: To prospectively evaluate diagnostic computed tomography (CT) and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) for identification of histopathologic response to neoadjuvant erlotinib, an epidermal growth factor receptor-tyrosine kinase inhibitor in patients with resectable non-small cell lung cancer (NSCLC). METHODS: This study was designed as an open-label phase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.